申请人:Garcia López Monica
公开号:US20130158029A1
公开(公告)日:2013-06-20
The invention refers to compounds of general formula (I)
having pharmacological activity towards the sigma receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which the sigma receptor is involved.
本发明涉及通式(I)的化合物,其具有对sigma受体的药理活性,以及制备这些化合物的过程,包括含有它们的制药组合物,以及它们用于治疗和/或预防涉及sigma受体的疾病的用途。